TEVA IMPACT TD Registry (Tardive Dyskinesia)
The purpose of this study is to uncover how tardive dyskinesia (TD) develops over time and its impact on individuals.
Inclusion Criteria:
Patients who are newly initiating deutetrabenazine as part of routine clinical practice.
What to Expect
As part of your usual care, you will complete questionnaires and visit your physician over 3 years to collect this information.
For more information click the link below or contact Heather Macnamara at hmacnamara@dentinstitute.com or 716-819-4117